What does MEDEVOX do?

MEDEVOX is registered with the CBE as active in: Overige persoonlijke diensten. Private Limited, started on 11 February 2009, 1 establishment.

What is the address of MEDEVOX?

The registered office of MEDEVOX is located at Pikdorenveld 24, 1950 Kraainem.

Is MEDEVOX still active?

Yes. According to the CBE (15 November 2026) MEDEVOX is active, legal situation “Normale toestand”, started on 11 February 2009.

Is MEDEVOX registered on Peppol?

Yes, MEDEVOX is registered on the Peppol network with ID 0208:0809740360.

What is the enterprise number of MEDEVOX?

The enterprise number of MEDEVOX is BE0809740360.

When was MEDEVOX founded?

MEDEVOX was founded on 11 February 2009.

Who are the directors of MEDEVOX?

According to the 2025 annual accounts, the directors of MEDEVOX are: OLIVIER BRIMBOIS.

Is MEDEVOX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 February 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did MEDEVOX make in 2025?

MEDEVOX posted a profit after taxes of € 52,300 in financial year 2025.

What is the revenue of MEDEVOX?

As a small company, MEDEVOX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 154,922.

MEDEVOX (Private Limited) - Kraainem - BE0809740360

Dossier MEDEVOX, printed on 15 November 2026 from databakkes.be/en/0809740360/medevox. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDEVOX from Kraainem, company number BE0809740360, closed financial year 2025 with a result of € 52,300 after tax. For that financial year MEDEVOX recorded a gross margin of € 154,922 and equity of € 285,376. Compared with financial year 2024, the result moved from € 115,240 to € 52,300. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 285,376

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 52,300

▼ 55% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 115,029

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 48,962 paid out

94 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 2,259

▼ 45% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,000

▲ 55% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 43,844

▼ 19% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 74,521 Gross margin 2022: € 74,521 First fiscal year in the series	€ 145,270 Gross margin 2023: € 145,270 ▲ 95% vs 2022 (€ 74,521) Favourable step	€ 178,238 Gross margin 2024: € 178,238 ▲ 23% vs 2023 (€ 145,270) Favourable step	€ 154,922 Gross margin 2025: € 154,922 ▼ 13% vs 2024 (€ 178,238) Unfavourable step	▼ 13%
Profit after taxes	€ 42,722 Profit after taxes 2022: € 42,722 First fiscal year in the series	€ 89,768 Profit after taxes 2023: € 89,768 ▲ 110% vs 2022 (€ 42,722) Favourable step	€ 115,240 Profit after taxes 2024: € 115,240 ▲ 28% vs 2023 (€ 89,768) Favourable step	€ 52,300 Profit after taxes 2025: € 52,300 ▼ 55% vs 2024 (€ 115,240) Unfavourable step	▼ 55%
Equity	€ 399,191 Equity 2022: € 399,191 First fiscal year in the series	€ 228,730 Equity 2023: € 228,730 ▼ 43% vs 2022 (€ 399,191) Unfavourable step	€ 282,037 Equity 2024: € 282,037 ▲ 23% vs 2023 (€ 228,730) Favourable step	€ 285,376 Equity 2025: € 285,376 ▲ 1% vs 2024 (€ 282,037) Favourable step	▲ 1%
Total debts	€ 47,116 Total debts 2022: € 47,116 First fiscal year in the series	€ 93,895 Total debts 2023: € 93,895 ▲ 99% vs 2022 (€ 47,116) Unfavourable step	€ 131,526 Total debts 2024: € 131,526 ▲ 40% vs 2023 (€ 93,895) Unfavourable step	€ 94,806 Total debts 2025: € 94,806 ▼ 28% vs 2024 (€ 131,526) Favourable step	▼ 28%
Cash	€ 2,166 Cash 2022: € 2,166 First fiscal year in the series	€ 53,959 Cash 2023: € 53,959 ▲ € 51,794 vs 2022 (€ 2,166) Favourable step	€ 94,049 Cash 2024: € 94,049 ▲ 74% vs 2023 (€ 53,959) Favourable step	€ 115,029 Cash 2025: € 115,029 ▲ 22% vs 2024 (€ 94,049) Favourable step	▲ 22%
Land & buildings	€ 47,708 Land & buildings 2022: € 47,708 First fiscal year in the series	€ 40,076 Land & buildings 2023: € 40,076 ▼ 16% vs 2022 (€ 47,708) Unchanged	€ 35,737 Land & buildings 2024: € 35,737 ▼ 11% vs 2023 (€ 40,076) Unchanged	€ 26,578 Land & buildings 2025: € 26,578 ▼ 26% vs 2024 (€ 35,737) Unchanged	▼ 26%
Retained profit	€ 386,791 Retained profit 2022: € 386,791 First fiscal year in the series	€ 216,330 Retained profit 2023: € 216,330 ▼ 44% vs 2022 (€ 386,791) Unfavourable step	€ 269,637 Retained profit 2024: € 269,637 ▲ 25% vs 2023 (€ 216,330) Favourable step	€ 272,976 Retained profit 2025: € 272,976 ▲ 1% vs 2024 (€ 269,637) Favourable step	▲ 1%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 260,229 Dividend 2023: € 260,229 Unchanged (€ 0) Unchanged	€ 61,933 Dividend 2024: € 61,933 ▼ 76% vs 2023 (€ 260,229) Unchanged	€ 48,962 Dividend 2025: € 48,962 ▼ 21% vs 2024 (€ 61,933) Unchanged	▼ 21%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 14,168 Bank debt 2024: € 14,168 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 14,168) Favourable step	▼ 100%
Balance sheet total	€ 446,307 Balance sheet total 2022: € 446,307 First fiscal year in the series	€ 322,625 Balance sheet total 2023: € 322,625 ▼ 28% vs 2022 (€ 446,307) Unchanged	€ 413,563 Balance sheet total 2024: € 413,563 ▲ 28% vs 2023 (€ 322,625) Unchanged	€ 431,526 Balance sheet total 2025: € 431,526 ▲ 4% vs 2024 (€ 413,563) Unchanged	▲ 4%

Key figures of MEDEVOX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about MEDEVOX the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to MEDEVOX?

What happened at MEDEVOX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 52,300 (▼ 55% vs 2024). filed late Source: NBB ↗
Feb 20, 2009 Incorporation, published in the Gazette. Source: Staatsblad ↗
Feb 9, 2009 New establishment in Kraainem. KBO

In short

From € 42,722 profit in 2022 to € 52,300 profit in 2025.

Paid € 157,051 in corporate taxes since 2022.

Best year ever: 2024, with € 115,240 profit.

Paid out € 371,123 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

OLIVIER BRIMBOIS

MEDEVOX

Behind MEDEVOX is OLIVIER BRIMBOIS.

Directors

According to the 2025 annual accounts

OLIVIER BRIMBOIS

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Pikdorenveld 24

1950 Kraainem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DAPHNE LIENART

€ 146,650 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

20 February 2009 Source: Deed ↗

BRIMBOIS Olivier Gaston(oprichter) 100%

Details

Company number: 0809.740.360
VAT number: BE 0809.740.360
Registered office: Pikdorenveld 24, 1950 Kraainem
Names & denominations: MEDEVOX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 February 2009
Peppol: Active · Active since 5 Jan 2026
Activities · NACE: Overige persoonlijke diensten

View on CBE Public ↗ Annual accounts (NBB) ↗